TickerFiles

ACTUATE THERAPEUTICS, INC. 10-K filing

Filed 2026-03-26 · Report date 2025-12-31 · 2025 FY

View Original SEC Filing

Filing metadata

Accession number
0001683168-26-002257
Form type
10-K
CIK
0001652935
Primary document
https://www.sec.gov/Archives/edgar/data/1652935/000168316826002257/actuate_i10k-123125.htm

Extracted primary information

This filing includes deterministic financial metrics extracted from public filing data for ACTUATE THERAPEUTICS, INC..

Reported financial metrics

MetricCurrentPriorChange
Operating Income$-22.5M--
Net Income$-22.2M--
Eps Basic-1.06--
Eps Diluted-1.06--
Cash And Equivalents$13.2M--
Total Assets$14.0M--
Total Liabilities$6.1M--
Shareholders Equity$7.9M--
Operating Cash Flow$-19.2M--